Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Viral Hemorrhagic Fever | Kisho | Kisho

Back to Viral Hemorrhagic Fever

Viral Hemorrhagic Fever — NIH Grants & Funding

Active and recent NIH-funded research on Viral Hemorrhagic Fever. Data from NIH RePORTER, last 36 months.

MONDO:0018087

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Viral Hemorrhagic Fever has active NIH research funding with 8 funded grants totaling $28.7M.

8funded grants from NIH

Portfolio: $7.1MCumulative: $28.7M6 active2 completed8 PIs7 institutions

1 new grant started in the last 12 months.

By Research Theme

Basic Science

Translational

Biomarker / Dx

1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$7.5M

FY22

$3.6M

FY23

$10.3M

FY24

$6.6M

FY25

$754K

FY26

By Funding Mechanism

R01

R03

R21

R44

ZIA

Funding Gap Analysis

Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Viral Hemorrhagic Fever. Strongest funded area: Translational / Drug Development. Largest gap: Epidemiology / Natural History.

Epidemiology / Natural HistoryPublished, Not NIH-Funded

14 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for viral hemorrhagic fever. Existing research activity suggests this may be a viable area for grant applications.

Adjacent Research(2 grants)

These grants mention Viral Hemorrhagic Fever as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(2)

OtherR01Completed

Advanced development of a viral entry inhibitor as a therapeutic for arenavirus hemorrhagic fever

AMBERG, SEAN·KINETA, INC.·SEATTLE, WA

$1,063,683 (FY2023)

NIH RePORTER

OtherR42Completed

Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses

HARTY, RONALD·FOX CHASE CHEMICAL DIVERSITY CENTER, INC·DOYLESTOWN, PA

$1,012,857 (FY2023)